| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 016TTR32QF |
| InChI Key | CMDJNMACGABCKQ-XVSRHIFFSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H23ClFN3O4S |
| Molecular Weight | 395.88 |
| AlogP | 1.75 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 62.3 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Rho-associated protein kinase inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase DMPK family
AGC protein kinase ROCK subfamily
|
- | 21.36 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Fuchs' Endothelial Dystrophy | 2 | D005642 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594454 |
| FDA SRS | 016TTR32QF |
| SureChEMBL | SCHEMBL20557243 |